Resources

Type of publications
Regions
Diseases

5192 results found

2024 ∙ JCVI

JCVI statement on COVID-19 vaccination in spring 2024 and considerations on future COVID-19 vaccination

  • Recommendation
  • Europe
  • United Kingdom
  • COVID-19
Download:
2024 ∙ NIAC

Updated recommendations for the vaccination of adults against measles

  • Recommendation
  • Europe
  • Ireland
  • Adults
  • Measles
Download:
2024 ∙ SAGE

Development of WHO immunization policy and strategic guidance

Download:
2024

Considerations to inform country COVID-19 vaccination decision-making

  • COVID-19
Download:
2024 ∙ ATAGI

ATAGI statement on Nirsevimab for the prevention of severe disease due to respiratory syncytial virus (RSV) in infants

  • Recommendation
  • Western Pacific
  • Australia
  • Children
  • RSV (Respiratory syncytial virus)
Download:
2024 ∙ Louise Henaff, Dace Zavadska, Mario Melgar, Johanna Fihman, Christoph Steffen, Joachim Hombach

The role of NITAGs in government decisions on vaccine use: insights from the Fifth Global NITAG Network meeting

Download:
2024 ∙ NACI

Guidance on an additional dose of COVID-19 vaccines in the spring for individuals at high risk of severe illness due to COVID-19

  • Recommendation
  • Americas
  • Canada
  • Older adults
  • COVID-19
Download:
2024

Meningococcal vaccines: WHO position paper on the use of multivalent meningococcal conjugate vaccines in countries of the African meningitis belt, January 2024

  • Position paper
  • Meningococcal disease
Download:
2023 ∙ Sadat Larijani, M. Doroud, D. Banifazl, M. Karami, A. Bavand, A. Ashrafian, F. Ramezani, A.

A landscape on disorders following different COVID-19 vaccination: a systematic review of Iranian case reports

  • Eastern Mediterranean
  • Islamic Republic of Iran
  • All age groups
  • COVID-19
  • Safety
Methodological quality (AMSTAR 2):
Critically low
2023 ∙ Ikeokwu, A. E. Adeniran, O. F. Marwizi, F. M. Kolade-Ernest, O. J. Solomon, R. O. Ogedengbe, W. Onyemarin-Henry, P. Okpo, N. C. Onyinye, O.

A Meta-Analysis To Ascertain the Effectiveness of COVID-19 Vaccines on Clinical Outcomes in Patients With COVID-19 Infection in North America

  • Americas
  • Adults
  • Older adults
  • COVID-19
  • Efficacy/effectiveness
Methodological quality (AMSTAR 2):
Critically low
Loading...